Cita APA

Vrede, S. W., van Weelden, W. J., Visser, N. C. M., van der Putten, L. J. M., Van de Vijver, K., Colas Ortega, E., . . . Moiola, C. P. (2021). Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer.

Citación estilo Chicago

Vrede, S. W., Willem Jan van Weelden, N. C. M. Visser, L. J. M. van der Putten, Koen Van de Vijver, Eva Colas Ortega, Antonio Gil Moreno, Johan Bulten, y Cristian Pablo Moiola. Immunohistochemical Biomarkers Are Prognostic Relevant in Addition to the ESMO-ESGO-ESTRO Risk Classification in Endometrial Cancer. 2021.

Cita MLA

Vrede, S. W., et al. Immunohistochemical Biomarkers Are Prognostic Relevant in Addition to the ESMO-ESGO-ESTRO Risk Classification in Endometrial Cancer. 2021.